The meeting reviewed strong FY25 results with 7.5% EBITDA growth, maintained dividends, and strategic investments in distribution, digital health, and animal care. Board renewal and director elections were addressed, with a focus on sustainability and future growth initiatives.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.